Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs iShares Semiconductor ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B), while iShares Semiconductor ETF trades at $574.29 (market cap $48.60B). The key difference: iShares Semiconductor ETF is far larger — about 21.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and iShares Semiconductor ETF is more actively traded (4,851,301 versus 3,128,960). Which is the better fit depends on your goals.
| SLS | SOXX | |
|---|---|---|
Market Cap | $2.28B | $48.60B |
Volume | 3,128,960 | 4,851,301 |
Sector | Health | Sector/Thematic |
52-Week High | $15.46 | $655.01 |
52-Week Low | $1.39 | $268.10 |
Enterprise Value | $2.15B | — |
Typical Hold Time | — | 46 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXX trades at $582.94, down 1.1% on the day, with technical indicators showing a bullish trend supported by moving averages but overbought RSI levels. The semiconductor ETF benefits from strong AI-driven demand, with recent news highlighting sector momentum and major acquisitions. A 1:3 stock split is scheduled for November 2026, while dividend payments remain modest.
The outlook remains positive due to robust AI infrastructure growth projections, though high valuations and concentration risks warrant caution. Key risks include Michael Burry's bearish bets and potential sector rotation. Analyst sentiment is generally favorable, with earnings growth expected to support further upside if macroeconomic conditions remain stable.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
